How the immune system curbs its own mistakes

January 11, 2018, Rockefeller University

When we encounter a pathogen, the immune system is usually able to respond quickly and forcefully to protect us from infection. Some of its preparedness is inherent in the process by which white blood cells called B cells make antibodies, proteins fine-tuned to recognize a specific invader. Within structures called germinal centers, B cells undergo many mutations to diversify—and when a pathogen attacks, those cells making the most potent antibodies are singled out and start multiplying quickly.

This system carries a risk, however: if not kept in check, the high mutation rates of B cells, along with their rapid proliferation, may destabilize the genome and lead to cancer.

In recent findings published in Science, Christian Mayer, a postdoctoral fellow in Michel Nussenzweig's laboratory, shed light on how the dangerous behavior of B cells is curbed by apoptosis, a process that programs cells to die. The researchers found that apoptosis is controlled differently within two zones of the germinal center, and high rates of apoptosis keep the size of these structures stable over time.

These findings could provide clues for developing prevention or treatment strategies for certain categories of lymphoma, cancers that arise in .

Explore further: Genetic control of immune cell proliferation

More information: Christian T. Mayer et al. The microanatomic segregation of selection by apoptosis in the germinal center, Science (2017). DOI: 10.1126/science.aao2602

Related Stories

Genetic control of immune cell proliferation

April 19, 2017
Germinal centers are transient structures in the lymph nodes where antibody-producing B cells proliferate and differentiate at extraordinary rates. Germinal centers can be visually divided into a dark zone and light zone. ...

Discovery helps explain how B cells adapt to their targets

May 7, 2014
(Medical Xpress)—Over the weeks following an invasion by a disease-causing microbe, the human immune system fine tunes its defenses, producing proteins called antibodies that are ever more precisely targeted at the invader. ...

Scientists discover an essential mechanism in the immune response

July 5, 2017
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have discovered that the transcriptional regulator CTCF plays an essential role in antibody production. The study, led by Dr. Almudena ...

Imaging studies open a window on how effective antibodies are formed

September 24, 2014
Sometimes, in order to understand what's happening in the immune system, you just have to watch it. By imaging the immune response, researchers have observed how two types of immune cells, T and B cells, interact with one ...

Solving puzzle of B-cell lymphoma development

September 23, 2012
Germinal centers are sites in the organs of the lymphatic system, formed during the course of an immune response to infection, where B cells intensely proliferate and modify their DNA in order to produce antibodies specific ...

Cell division speeds up as part of antibody selection, study shows

July 16, 2015
It's a basic principle of immunology: When a germ invades, the body adapts to that particular target and destroys it. But much remains unknown about how the immune system refines its defensive proteins, called antibodies, ...

Recommended for you

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.